Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -14.01x is 86% above its 4-year average of -97.51x, near the high end of its 4-year range (-545.99x–-8.13x).
14.49% below its 12-month average of -12.24x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2025 (2025-09-30): -12.12x.
INTEREST COVERAGE RATIO
-14.01x
INTEREST COVERAGE RATIO AVG TTM
-12.24x
INTEREST COVERAGE RATIO AVG 3Y
-33.44x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-14.49%
CURRENT VS 3Y AVG
+58.10%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-3.98x
median of 336 covered companies
CURRENT VS SECTOR MEDIAN
-252.45%
vs the sector median at left
Envoy Medical, Inc.
Market Cap
$51.78M
Interest Coverage Ratio
-14.01x
TTM Avg
-12.24x
3Y Avg
-33.44x
5Y Avg
N/A
Market Cap
$51.17M
Interest Coverage Ratio
-145.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$52.80M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$53.11M
Interest Coverage Ratio
-6.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.25M
Interest Coverage Ratio
3.24x
TTM Avg
3.06x
3Y Avg
3.54x
5Y Avg
8.88x
Market Cap
$53.53M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Envoy Medical, Inc. (COCH) | $51.78M | -14.01x | -12.24x | -33.44x | N/A |
| INmune Bio, Inc. (INMB)vs › | $51.04M | N/A | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | N/A | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $51.17M | -145.74x | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.80M | N/A | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $52.67M | N/A | N/A | N/A | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $53.11M | -6.14x | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $50.25M | 3.24x | 3.06x | 3.54x | 8.88x |
| Connect Biopharma Holdings Limited (CNTB)vs › | $53.53M | N/A | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $49.84M | -8.61x | N/A | N/A | N/A |
Interest Coverage
-14.0x
Debt/Equity
0.25
Current Ratio
1.73
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-09-30 | -12.12x |
| 2025-06-30 | -8.13x |
| 2025-03-31 | -10.32x |
| 2024-12-31 | -11.78x |
| 2024-09-30 | -18.84x |
| 2024-06-30 | -36.82x |
| 2024-03-31 | -136.06x |
| 2021-09-30 | -545.99x |
